Concomitant Use of Analgesics and EGFR TKIs in Lung Cancer Patients: Outcomes and Perspectives From a Finnish Retrospective Register–Based Study by Laura S. Puuniemi, Sanna M. E. Iivanainen, Martti Arffman, Riitta L. Kaarteenaho, Jussi P. Koivunen

Subjects: “…EGFR TKI…”
Get full text

Mild clinical course of COVID-19 infection in chronic myeloid leukemia (CML) patients receiving tyrosine kinase inhibitors (TKIs) without interruption by Judit Demeter, Julia Weisinger, Zsolt Nagy

Subjects: Get full text

The RAS‐related GTPase RHOB confers resistance to EGFR‐tyrosine kinase inhibitors in non‐small‐cell lung cancer via an AKT‐dependent mechanism by Olivier Calvayrac, Julien Mazières, Sarah Figarol, Claire Marty‐Detraves, Isabelle Raymond‐Letron, Emilie Bousquet, Magali Farella, Estelle Clermont‐Taranchon, Julie Milia, Isabelle Rouquette, Nicolas Guibert, Amélie Lusque, Jacques Cadranel, Nathalie Mathiot, Ariel Savina, Anne Pradines, Gilles Favre

Subjects: Get full text

Molecular characteristics and responses to EGFR tyrosine kinase inhibitors in non-small cell lung cancer patients with EGFR exon 19 insertions by Yang Li, Yunfeng Ni, Feng Lv, Yan Shi, Yedan Chen, Xiaoying Wu, Jiaohui Pang, Long Huang, Yang Shao, Tao Wang, Jie Min, Yang Song

Subjects: Get full text

Misdiagnosis of bilateral breast metastases as primary benign tumors secondary to lung large-cell neuroendocrine carcinoma: a case report by Yu Zheng, Tingting Ding, Rong Wang

Subjects: Get full text

Management of Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia in a Jehovah’s Witness using chemotherapy free regimen: A case report and review of literature by Muhammad Hassan Raza, Eiraj Khan, Alexis M Desjarlais, Salman Fazal

Subjects: Get full text

Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non‐small cell lung cancer by Azhar Ali, Elena Levantini, Jun Ting Teo, Julian Goggi, John G Clohessy, Chan Shuo Wu, Leilei Chen, Henry Yang, Indira Krishnan, Olivier Kocher, Junyan Zhang, Ross A Soo, Kishore Bhakoo, Tan Min Chin, Daniel G Tenen

Subjects: Get full text

Intracellular cholesterol: new functions and therapeutic approaches in NSCLC EGFR-TKI resistance by Linjuan Wang, Yue Qiu, Xiang Huang, Shimei Zhang, Min Zhao, Qiufang Chen

Subjects: Get full text

Kinomic profiling to predict sunitinib response of patients with metastasized clear cell Renal Cell Carcinoma by Jeannette C. Oosterwijk-Wakka, Liesbeth Houkes, Loes F.M. van der Zanden, Lambertus A.L.M. Kiemeney, Kerstin Junker, Anne Y Warren, Tim Eisen, Ulrich Jaehde, Marius T Radu, Rob Ruijtenbeek, Egbert Oosterwijk

Subjects: Get full text

Comparison of first-generation EGFR-TKIs combined with low-dose bevacizumab versus osimertinib in untreated advanced EGFR-mutated NSCLC by Yingqi Xu, Yidan Zhang, Hongping Jin, Hua Zhong, Jianlin Xu, Yuqing Lou, Runbo Zhong

Subjects: Get full text

Combination of Hepatic Arterial Infusion Chemotherapy with Tyrosine Kinase Inhibitor Provides Better Survival in Advanced Hepatocellular Carcinoma Patients by Liu CW, Lin PT, Teng W, Chen WT, Su CW, Hsieh YC, Lin CC, Lin CY, Lin SM

Subjects: Get full text

Survival Outcomes in EGFR‐Mutant Non‐Small Cell Lung Cancer With Brain Metastases: Kaplan–Meier and Cox Regression Analyses Across Treatment Stages by Haoran Qi, Qiang Qiao, Xiaorong Sun, Ligang Xing

Subjects: Get full text

Recent Advances in the Use of <i>Ganoderma lucidum</i> and <i>Coriolus versicolor</i> Mushrooms to Enhance the Anticancer Efficacy of EGFR-Targeted Drugs in Lung Cancer by Hang Zhang, Longling Wang, Yuet Wa Chan, William C. Cho, Zhong Zuo, Kenneth K. W. To

Subjects: “…EGFR-TKI…”
Get full text

EGFR‐TKIs Induced DPP4 Drives Metabolic Reprogramming of Persister Cells in Lung Cancer by Yuanzhou Zhang, Xiaojun Zhang, Xupeng Yang, Xingshi Chen, Yuehong Wang, Jingying Hu, Rui Liu, Xiaoying Luo

Subjects: Get full text

Diverse perspectives on proteomic posttranslational modifications to address EGFR-TKI resistance in non-small cell lung cancer by Yuhong Ma, Feng Zhang, Jin Li, Juan Li, Yanhua Li

Subjects: “…EGFR-TKI resistance…”
Get full text

High-dose furmonertinib plus bevacizumab in EGFR-mutant non-small cell lung cancer with brain metastases after resistance to third-generation EGFR-TKIs: A retrospective study by Yin Pan, Meichen Li, Mingjie Yu, Jing Chen, Hui Yu, Kaijing Liu, Likun Chen

Subjects: Get full text

The Use of Anaplastic Lymphoma Kinase Inhibitors in Non-Small-Cell Lung Cancer Treatment—Literature Review by Anita Gorzelak-Magiera, Małgorzata Domagała-Haduch, Jacek Kabut, Iwona Gisterek-Grocholska

Subjects: “…ALK-TKI…”
Get full text

Multimodal prediction of tyrosine kinase inhibitors therapy outcomes in advanced EGFR-mutated NSCLC patients by Xiaodong Chai, Hongxia Li, Moxuan Yang, Junyang Zeng, Genxiu Chen, Yongmeng Li, Wei Wang, Zichen Liu, Kun Li, Tongmei Zhang, Shuhao Wang, Nanying Che

Subjects: Get full text

Gilteritinib by Harini Raghunathan, Parathan Karunakaran

Subjects: Get full text

Long-term endocrine outcomes and quality of life in paediatric and young chronic myeloid leukaemia patients on tyrosine kinase inhibitor therapy: a prospective study from India by Rajiv Mohan, Chitrakshi Nagpal, Swasthik Upadhya, Akash Kumar, Rajesh Khadgawat, Sameer Bakhshi, Deepam Pushpam

Subjects: Get full text